A Milestone Achieved: Over $100 Million in Grants and Equity Raised Since 2009Read more
A Milestone Achieved: Over $100 Million in Grants and Equity Raised Since 2009Read more
Kelley Recognizes the Massachusetts Life Sciences Center for Its Aid to His CompanyRead more
Quad Technologies Inc (“Quad”), developer of a novel cell separation technology, has secured a substantial amount of capital from its Series A round to accelerate development of disruptive cell processing technologies for translational medicine applications. The investment has enabled Quad to launch its MagCloudz™ Streptavidin Cell Separation Kit, which is the first commercially available productRead more
Interested in incubating your company with InnoVenture Labs? Submit your application today!